This item was submitted to Loughborough's Institutional Repository (https://dspace.lboro.ac.uk/) by the author and is made available under the following Creative Commons Licence conditions.
For the full text of this licence, please go to: http://creativecommons.org/licenses/by-nc-nd/2.5/ 5 GLP-1R and also more generally for a better understanding of ligand-receptor interactions and activation 88 mechanisms in Family B GPCRs.
89
Binding of peptide ligands to Family B GPCRs is currently described by a two-domain model 90 (11, 12) (Table 2 ).
6
A series of hGLP-1R constructs were generated in which a single residue within a (Table 2 ). In particular Y152A (TM1), R190A (TM2), Y235A (TM3), R310A
120
(TM5) and H363A (TM6) expression was less than 25% of the wild type (WT) receptor.
121
With the exception of T391A (TM7), which had no effect, all other alanine substitutions influenced 
127
W284 to be at the top of TM4, our model suggests that this residue may be at the proximal end of EC2, 7 forskolin response) (Table 3 ). In addition to H363A, which was essentially uncoupled despite agonist 143 binding, the mutations K197A (TM2), W284A (EC2) and R310A (TM5) resulted in much greater 144 reductions in agonist potency than affinity (Tables 2 and 3) . A similar profile of potency differences 145 between the wild-type receptor and the mutated receptors was observed irrespective of whether GLP-1 7-146 37 or GLP-1 7-36 amide was used as the agonist in the functional assays (data not shown).
147
Although expression levels did vary amongst the receptor constructs, there was little evidence to 148 suggest this had a major impact on agonist potencies. For example, despite the expression of Y152A 149 being substantially lower than the wild-type receptor, agonist potency was reduced in line with affinity.
150
Indeed, there were no instances where potency but not affinity was reduced. from intra-or inter-molecular proximity.
194
The three dimensional structure of the receptor was examined to investigate the possible interactions Interactions of the mutated residues with other amino acids in the GLP-1R structure as defined by the 198 final model are summarised in As previously suggested (30), we show L:F12 sits in a hydrophobic pocket, and that L:Y19 forms an 330 electrostatic interaction with the receptor, although our model suggests involvement of N300 rather than 14 between G295 and L:H7 and between K202 (TM2) and L:E9 are also highlighted in our model ( Table 4 . These override sections were specifically aligned to match the proline position and 514 the best of the available templates chosen by RMSD to the original template at either end of the helix.
515
For illustration, a helical wheel projection was constructed from the final model (using a program by 
530
Whatman GF/C glass filters and 125 I-exendin 9-39 (specific activity 2200Ci mmol thereof is based on the BLOSUM62 substitution matrix (54) with residues being considered conserved 698 with a score of ≥0. Note that of the residues mutated in the GLP-1R, least conservation is shown in was more severely affected than the binding affinity of the antagonist, exendin 9-39, whereas a ratio of 731 <0.5 was taken to indicate that binding affinity of exendin 9-39 was more severely affected than the binding affinity of GLP-1 7-36 amide. was greater than the reduction in agonist affinity, K I (see Table 2 ). experiments on all receptor constructs are given in Table 2 . Similarly, potency estimates and E max values 867 for cAMP generation derived from experiments on all receptor constructs are given in Table 3 . 
897
Residues mutated in the current study are circled in red. 
